Size	Price	VIP Price	US Stock	Global Stock	In Stock
{[ item.pr_size ]}		Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

CAS No. :	129-46-4
Formula :	C₅₁H₃₄N₆Na₆O₂₃S₆
M.W :	1429.17
SMILES Code :	O=C(NC1=CC(C(NC2=CC(C(NC3=CC=C(S(=O)([O-])=O)C4=CC(S(=O)([O-])=O)=CC(S(=O)([O-])=O)=C34)=O)=CC=C2C)=O)=CC=C1)NC5=CC(C(NC6=CC(C(NC7=CC=C(S(=O)([O-])=O)C8=CC(S(=O)([O-])=O)=CC(S(=O)([O-])=O)=C78)=O)=CC=C6C)=O)=CC=C5.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]
Synonyms :	Suramin hexasodium salt; Suramin Sodium; NF 060
MDL No. :	MFCD00210217
InChI Key :	VAPNKLKDKUDFHK-UHFFFAOYSA-H
Pubchem ID :	8514

GHS Pictogram:
Signal Word:	Warning
Hazard Statements:	H302-H315-H319-H335
Precautionary Statements:	P261-P280-P301+P312-P302+P352-P305+P351+P338

DU145 cells	300 µg/ml	10 minutes	To determine the effects of suramin on tyrosine phosphorylation in DU145 cells, it was found that suramin significantly increased the tyrosine phosphorylation of 75 and 135 kDa proteins.	PMC443367
LNCaP cells	300 µg/ml	10 minutes	To determine the effects of suramin on tyrosine phosphorylation in LNCaP cells, it was found that suramin significantly increased the tyrosine phosphorylation of 75 and 135 kDa proteins.	PMC443367
Lycopersicon peruvianum suspension-cultured cells	700 µM	10 minutes	Suramin inhibited the alkalinization of the medium induced by systemin, chitosan, and pmg elicitor.	PMC34024
monocytes	200 µM	2 days	Suramin reduced the expression of FcγRI, FcγRII, FcεRII, and FcαR on monocytes and impaired their phagocytic capacity.	PMC1422361
Chinese hamster fibrosarcoma cells (DC-3F)	50 µM	24 hours	Determine the intracellular distribution of Suramin, results showed Suramin was predominantly located in the nucleus.	PMC48796
KB cells	300 μM	24 hours and 48 hours	To investigate the effect of Suramin on the growth of KB cells, results showed that Suramin was able to sustain the growth of KB carcinoma cells cultured under serum-free conditions.	PMC442984
HEK293T cells	0.02 - 5 mM	4 hours	To evaluate the neutralizing effect of Suramin on SARS-CoV-2 pseudotyped viral particles, results showed that Suramin exhibited broad entry inhibition among all three variants tested (wild type, Delta, and Omicron)	PMC10082822
Vero E6 cells	5, 10, 50, 100, 1000, 10000 µM	48 hours	To evaluate the cytotoxicity of Suramin on Vero E6 cells, results showed very low cytotoxicity (<20%) even at suramin concentrations up to 10 mM	PMC10082822
Lycopersicon peruvianum suspension-cultured cells	1 mM	5 minutes	Suramin inhibited the activation of the 48-kDa MBP kinase induced by systemin, chitosan, and pmg elicitor.	PMC34024
FaDu cells	10 –25 μM	6 weeks	inhibited telomerase activity, leading to gradual telomere shortening (maximum of 30%) and cell senescence	PMC4287294
PC3 cells	10 –25 μM	6 weeks	inhibited telomerase activity, leading to gradual telomere shortening (maximum of 30%) and cell senescence	PMC4287294
MCF7 cells	10 –25 μM	6 weeks	inhibited telomerase activity, leading to gradual telomere shortening (maximum of 30%) and cell senescence	PMC4287294
Saos-2 cells	10 –25 μM	6 weeks	no telomere shortening was observed	PMC4287294
A431 cells	100 μM and 300 μM	72 hours and 96 hours	To investigate the effect of Suramin on EGFR in A431 cells, results showed that Suramin treatment led to a dramatic reduction in EGFR abundance and a shift in EGFR mobility, indicating Suramin-induced downregulation of EGFR.	PMC442984
U937 cells	50-200 µM	8-72 hours	Suramin inhibited the proliferation of U937 cells and reduced the expression of FcγRI, FcγRII, FcεRII, and FcαR.	PMC1422361
U-266 cells	30 μM	90 minutes	Suramin inhibited the binding of 125I-IL-6 to U-266 cells, with a half-maximal inhibition concentration of 30 μM	PMC288393
MCF-7 cells	300 μM	90 minutes	Suramin inhibited the binding of 125I-TNFα to MCF-7 cells, with a half-maximal inhibition concentration of 300 μM	PMC288393
PC3 cells	300 µg/ml	seconds	To determine the effects of suramin on tyrosine phosphorylation in PC3 cells, it was found that suramin significantly increased the tyrosine phosphorylation of several distinct proteins.	PMC443367
U2OS cells	62.5 to 500 μM		Suramin at 62.5 μM accumulated p27 and CDT1, and at 250-500 μM accumulated Nrf2, indicating that Suramin inhibits CRL-mediated ubiquitination, leading to the accumulation of CRL substrates.	PMC4833235
B-9 cells	30 μM		Suramin inhibited the proliferation of B-9 cells in response to IL-6, with a half-maximal inhibition concentration of 30 μM	PMC288393

BALB/c X DBA/2 (CD)F1 mice	C-26 adenocarcinoma model	intraperitoneal injection	75 mg/kg	injected on days 7 and 12	Suramin significantly improved weight loss in C-26 adenocarcinoma model mice, reducing muscle and fat tissue wasting and hypoglycemia	PMC288393
Mice	Pkd1-deficient mouse model	Intraperitoneal injection	60 mg/kg	Twice a week for 8 weeks	Suramin significantly reduced renal cyst densities, cell proliferation, and macrophage infiltration, but did not improve kidney function	PMC9369130
Tomato plants	14-day-old tomato plants	Supplied through cut stems	700 µM	1-hour pretreatment	Suramin inhibited the synthesis of serine proteinase inhibitors I and II induced by systemin and completely inhibited the synthesis of inhibitors induced by wounding.	PMC34024
Mice	FaDu tumor model	intravenous injection	10 mg/kg	twice a week for 6 weeks	resulted in telomere shortening of >40% in tumor cells	PMC4287294

{[proInfo.proName]}

CAS No.: 129-46-4

{[proInfo.proName]}

CAS No.: 129-46-4

Alternative Products

Product Details of Suramin sodium salt

Safety of Suramin sodium salt

Related Pathways of Suramin sodium salt

Isoform Comparison

Biological Activity

Protocol

References

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator

NCT00001230	-		Recruiting	-	United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) 800-441-1222 ext TTY8864111010 prpl@cc.nih.gov Less <<
NCT02347332	Recurrent or Metastatic Head a... More >>nd Neck Carcinoma Less <<	Phase 3	Active, not recruiting	June 2018	-
NCT02871284	Exercise Chem... More >>otherapy-induced Polyneuropathy Less <<	Phase 2 Phase 3	Recruiting	December 2019	Germany ... More >> National Center for Tumor Diseases Recruiting Heidelberg, Germany, 69120 Contact: Joachim Wiskemann, Dr. joachim.wiskemann@nct-heidelberg.de Contact: Jana Müller jana.mueller@nct-heidelberg.de Less <<
NCT00003038	Adrenocortical Carcinoma ... More >> Breast Cancer Colorectal Cancer Prostate Cancer Unspecified Adult Solid Tumor, Protocol Specific Less <<	Phase 1	Completed	-	United States, Minnesota ... More >> Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 Less <<
NCT00001266	Prostatic Neoplasm	Phase 2	Completed	-	United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT00006476	Bladder Cancer	Phase 1	Completed	-	United Kingdom ... More >> Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Less <<
NCT00004073	Brain and Central Nervous Syst... More >>em Tumors Less <<	Phase 2	Completed	-	United States, Alabama ... More >> University of Alabama Comprehensive Cancer Center Birmingham, Alabama, United States, 35294 United States, Florida H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 United States, Georgia Emory University Hospital - Atlanta Atlanta, Georgia, United States, 30322 United States, Maryland Johns Hopkins Oncology Center Baltimore, Maryland, United States, 21231 United States, Massachusetts Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 United States, Michigan Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, North Carolina Comprehensive Cancer Center of Wake Forest University Baptist Medical Center Winston-Salem, North Carolina, United States, 27157-1082 United States, Pennsylvania University of Pennsylvania Cancer Center Philadelphia, Pennsylvania, United States, 19104 United States, Texas University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78284-7811 Less <<
NCT00001381	Bladder Neoplasms ... More >> Carcinoma, Transitional Cell Less <<	Phase 1	Completed	-	United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT00002881	Prostate Cancer	Phase 3	Completed	-	United States, District of Col... More >>umbia Walter Reed Army Medical Center Washington, District of Columbia, United States, 20307-5000 Less <<
NCT00006929	Recurrent Non-small Cell Lung ... More >>Cancer Stage IIIB Non-small Cell Lung Cancer Stage IV Non-small Cell Lung Cancer Less <<	Phase 2	Completed	-	United States, Ohio ... More >> Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT00002639	Brain and Central Nervous Syst... More >>em Tumors Less <<	Phase 2	Completed	-	United States, Georgia ... More >> Department of Neurosurgery - Emory Atlanta, Georgia, United States, 30322 Less <<
NCT01671332	Carcinoma, Non Small Cell Lung	Phase 2	Unknown	December 2016	United States, Wisconsin ... More >> University of Wisconsin Carbone Comprehensive Cancer Center Madison, Wisconsin, United States, 53792 Medical College of Wisconsin Milwaukee, Wisconsin, United States Less <<
NCT00002652	Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less <<	Phase 2	Completed	-	United States, Arkansas ... More >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 Less <<
NCT00083109	Recurrent Renal Cell Carcinoma... More >> Stage IV Renal Cell Cancer Less <<	Phase 1 Phase 2	Completed	-	United States, Ohio ... More >> Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 Less <<
NCT00054028	Recurrent Breast Cancer ... More >> Stage IIIB Breast Cancer Stage IV Breast Cancer Less <<	Phase 1 Phase 2	Completed	-	United States, Ohio ... More >> Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT00066768	Recurrent Non-small Cell Lung ... More >>Cancer Stage IIIB Non-small Cell Lung Cancer Stage IV Non-small Cell Lung Cancer Less <<	Phase 1	Completed	-	United States, Ohio ... More >> Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT01038752	Non-small Cell Lung Cancer	Phase 2	Terminated	-	United States, Illinois ... More >> John H Stroger Jr Hospital of Cook County Chicago, Illinois, United States, 60612 United States, Virginia Virginia Commonwealth University Massey Cancer Center Richmond, Virginia, United States, 23298 Less <<
NCT00054028	-		Completed	-	-
NCT02508259	Autism Spectrum Disorders	Phase 1 Phase 2	Completed	-	United States, California ... More >> University of California, San Diego School of Medicine La Jolla, California, United States, 92093 Less <<
NCT01038752	-		Terminated	-	-
NCT00002921	Adrenocortical Carcinoma	Phase 2	Terminated(Permanently Closed ... More >>Due to Lack of Accrual) Less <<	-	-
NCT00002723	Prostate Cancer	Phase 3	Completed	-	-
NCT06058962	Autism Spectrum Disorder	PHASE2	COMPLETED	2021-03-15	PaxMedica, Tarrytown, New York... More >>, 10591, United States Less <<

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed